Jennifer Hammond

3.4k total citations · 2 hit papers
79 papers, 2.2k citations indexed

About

Jennifer Hammond is a scholar working on Infectious Diseases, Epidemiology and Cognitive Neuroscience. According to data from OpenAlex, Jennifer Hammond has authored 79 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Infectious Diseases, 21 papers in Epidemiology and 11 papers in Cognitive Neuroscience. Recurrent topics in Jennifer Hammond's work include COVID-19 Clinical Research Studies (12 papers), HIV/AIDS drug development and treatment (10 papers) and Autism Spectrum Disorder Research (10 papers). Jennifer Hammond is often cited by papers focused on COVID-19 Clinical Research Studies (12 papers), HIV/AIDS drug development and treatment (10 papers) and Autism Spectrum Disorder Research (10 papers). Jennifer Hammond collaborates with scholars based in United States, United Kingdom and Canada. Jennifer Hammond's co-authors include Andréa C. LeBlanc, Cynthia G. Goodyer, Hui Liu, Catherine Bergeron, Morrie M. Gelfand, Mark Trifiro, Quynh Anh Le, Brian A. Iwata, Scott S. Hall and Sarah E. Bloom and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Jennifer Hammond

73 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Therapeutics for COVID-19

2023 65 citations Jennifer Hammond et al. profile →
Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19

2024 50 citations Jennifer Hammond, Robert J. Fountaine et al. New England Journal of Medicine profile →

Peers

Jennifer Hammond

EPIDE

DEP

Luis Álvarez Spain

Brian Kirby Ireland

Xuewen Wang China

Judy King United States

Hyun-Kyung Lee South Korea

Rachel Anderson United States

Sarah Thomas United States

Sarah Robertson United States

Lan Yu China

Linda R. Peterson United States

Luis Álvarez Spain

Jennifer Hammond

105 ×0.2

1.3k ×2.9

545 ×1.6

EPIDE

79 ×0.3

DEP

148 ×0.6

Citations per year, relative to Jennifer Hammond Jennifer Hammond (= 1×) peers Luis Álvarez

Countries citing papers authored by Jennifer Hammond

Since Specialization

Citations

This map shows the geographic impact of Jennifer Hammond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Hammond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Hammond more than expected).

Fields of papers citing papers by Jennifer Hammond

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer Hammond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Hammond. The network helps show where Jennifer Hammond may publish in the future.

Co-authorship network of co-authors of Jennifer Hammond

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer Hammond. A scholar is included among the top collaborators of Jennifer Hammond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer Hammond. Jennifer Hammond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Weinstein, Edward A., Roger Paredes, Annie Gardner, et al.. (2025). Extended nirmatrelvir–ritonavir treatment durations for immunocompromised patients with COVID-19 (EPIC-IC): a placebo-controlled, randomised, double-blind, phase 2 trial. The Lancet Infectious Diseases. 25(11). 1243–1253. 3 indexed citations

Baniecki, Mary Lynn, K. Devendra, Qingyi Yang, et al.. (2025). Integrated virologic analysis of resistance to nirmatrelvir/ritonavir in individuals across four phase 2/3 clinical studies for the treatment of COVID-19. EBioMedicine. 118. 105819–105819.

Brennan, Kathleen, Jennifer Hammond, Annette Zygmunt, et al.. (2025). Standardizing early cerebral palsy detection in high-risk infants: reducing age at diagnosis through a quality improvement initiative. Journal of Perinatology.

Hammond, Jennifer, Carla Yunis, Robert J. Fountaine, et al.. (2024). Oral Nirmatrelvir–Ritonavir as Postexposure Prophylaxis for Covid-19. New England Journal of Medicine. 391(3). 224–234. 6 indexed citations

Baniecki, Mary Lynn, Zhenyu Wang, Yan Chen, et al.. (2023). 361. Evaluation of Resistance to Nirmatrelvir/ritonavir in Evaluation of Protease Inhibition for COVID-19 (EPIC) High-Risk and Standard-Risk Clinical Trials. Open Forum Infectious Diseases. 10(Supplement_2). 1 indexed citations

Ford, Emily S., William Simmons, Ellora Karmarkar, et al.. (2022). Successful Treatment of Prolonged, Severe Coronavirus Disease 2019 Lower Respiratory Tract Disease in a B cell Acute Lymphoblastic Leukemia Patient With an Extended Course of Remdesivir and Nirmatrelvir/Ritonavir. Clinical Infectious Diseases. 76(5). 926–929. 40 indexed citations

Torres, Antoni, Àlex Soriano, Edit Remák, et al.. (2022). Ceftaroline Fosamil for the Empiric Treatment of Hospitalized Adults with cSSTI: An Economic Analysis from the Perspective of the Spanish National Health System. SHILAP Revista de lepidopterología. 3 indexed citations

Hammond, Jennifer, Charlotte Wool, & Elvira Parravicini. (2020). Assessment of Healthcare Professionals' Self-Perceived Competence in Perinatal/Neonatal Palliative Care After a 3-Day Training Course. Frontiers in Pediatrics. 8. 571335–571335. 11 indexed citations

Wright, James G., et al.. (2019). A Retrospective Analysis of Probability of Target Attainment in Community-Acquired Pneumonia: Ceftaroline Fosamil Versus Comparators. Infectious Diseases and Therapy. 8(2). 185–198. 16 indexed citations

10.

Acker, Karen P., Stephanie A. Schnell, Jennifer Hammond, et al.. (2017). Scalp Lesions in a Pediatric Patient with Hyper IgM Syndrome: Clinical and Histologic Mimicry of Cryptococcus neoformans Infection. The Journal of Pediatrics. 192. 256–258. 4 indexed citations

11.

Hall, Scott S., et al.. (2014). Using Discrete Trial Training to Identify Specific Learning Impairments in Boys with Fragile X Syndrome. Journal of Autism and Developmental Disorders. 44(7). 1659–1670. 7 indexed citations

12.

Fritz, Jennifer N., Brian A. Iwata, Jennifer Hammond, & Sarah E. Bloom. (2013). EXPERIMENTAL ANALYSIS OF PRECURSORS TO SEVERE PROBLEM BEHAVIOR. Journal of Applied Behavior Analysis. 46(1). 101–129. 55 indexed citations

13.

Hammond, Jennifer, Brian A. Iwata, Griffin W. Rooker, Jennifer N. Fritz, & Sarah E. Bloom. (2013). EFFECTS OF FIXED VERSUS RANDOM CONDITION SEQUENCING DURING MULTIELEMENT FUNCTIONAL ANALYSES. Journal of Applied Behavior Analysis. 46(1). 22–30. 49 indexed citations

14.

Hammond, Jennifer, et al.. (2011). Effects of computerized match-to-sample training on emergent fraction–decimal relations in individuals with fragile X syndrome. Research in Developmental Disabilities. 33(1). 1–11. 14 indexed citations

15.

Hammond, Jennifer, et al.. (2011). EVALUATION OF FIXED MOMENTARY DRO SCHEDULES UNDER SIGNALED AND UNSIGNALED ARRANGEMENTS. Journal of Applied Behavior Analysis. 44(1). 69–81. 14 indexed citations

16.

Jacobson, Ira M., Paul J. Pockros, Jacob Lalezari, et al.. (2010). 2005 VIROLOGIC RESPONSE RATES FOLLOWING 4 WEEKS OF FILIBUVIR IN COMBINATION WITH PEGYLATED INTERFERON ALFA-2A AND RIBAVIRIN IN CHRONICALLY-INFECTED HCV GENOTYPE-1 PATIENTS. Journal of Hepatology. 52. S465–S465. 18 indexed citations

17.

Mori, Jo, et al.. (2010). 35 GENOTYPIC CHARACTERISATION OF FILIBUVIR (PF-00868554) RESISTANCE IN PATIENTS RECEIVING FOUR WEEKS CO-ADMINISTRATION OF FILIBUVIR WITH PEGIFN/RBV (12 WEEK ANALYSIS). Journal of Hepatology. 52. S15–S15. 7 indexed citations

18.

Andrews, Margaret, et al.. (2009). Implementation and sustainability of the nursing and midwifery standards for mentoring in the UK. Nurse Education in Practice. 10(5). 251–255. 21 indexed citations

19.

Jodoin, Julie, et al.. (2009). Loss of Anti-Bax Function in Gerstmann-Sträussler-Scheinker Syndrome-Associated Prion Protein Mutants. PLoS ONE. 4(8). e6647–e6647. 9 indexed citations

20.

Hammond, Jennifer, et al.. (2001). Daytime Effects of Raised Pavement Markers on Horizontal Curves. ITE journal. 71(8). 38–41. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact